Literature DB >> 12533033

Total skin electron irradiation in mycosis fungoides: comparison between a modified Christie Hospital translational technique and the Stanford technique.

Y Anacak1, Z Arican, K Drumea, E Rosenblatt, A Tamir, L Chetver, M Stein, R Bar Deroma, A Kuten.   

Abstract

Seventy-one patients with mycosis fungoides (MF) were treated by Total skin electron irradiation (TSEI) using either a modified Christie Hospital translational technique (44 pts) or a six dual-field Stanford technique (27 pts). There was no statistical difference in response rate, disease-free survival and overall survival between the two irradiation techniques. However, the Stanford technique was significantly less toxic than the modified Christie Hospital technique.

Entities:  

Mesh:

Year:  2002        PMID: 12533033     DOI: 10.1080/1042819021000016177

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  3 in total

Review 1.  The current management of mycosis fungoides and Sézary syndrome and the role of radiotherapy: Principles and indications.

Authors:  Ercole Mazzeo; Laura Rubino; Michela Buglione; Paolo Antognoni; Stefano Maria Magrini; Francesco Bertoni; Manuela Parmiggiani; Paola Barbieri; Filippo Bertoni
Journal:  Rep Pract Oncol Radiother       Date:  2013-08-13

2.  Simultaneous integrated boost with helical arc radiotherapy of total skin (HEARTS) to treat cutaneous manifestations of advanced, therapy-refractory cutaneous lymphoma and leukemia - dosimetry comparison of different regimens and clinical application.

Authors:  Chen-Hsi Hsieh; Hui-Ju Tien; Yuan-Bin Yu; Yuan-Hung Wu; Pei-Wei Shueng; Yueh-Feng Lu; Shan-Ying Wang; Li-Ying Wang
Journal:  Radiat Oncol       Date:  2019-01-28       Impact factor: 3.481

3.  Tomotherapy as an Alternative Irradiative Treatment for Complicated Keloids.

Authors:  Yu-Fang Lin; Pei-Wei Shueng; Tyng-Luen Roan; Dun-Hao Chang; Yen-Chen Yu; Che-Wei Chang; An-Ta Kuo; Yo-Shen Chen; Hsiu-Wen Hsiao; Hui-Ju Tien; Chen-Hsi Hsieh
Journal:  J Clin Med       Date:  2020-11-20       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.